Icotinib Hydrochloride

Icotinib hydrochloride (BPI-2009H) is a highly potent and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) with an IC50 of 5 nM, utilized in the treatment of non-small cell lung cancer (NSCLC).

Price Not Available 5mg Icotinib Hydrochloride Supplier Page

Trivial name	BPI-2009H
Catalog Number	E4884
Molecular Formula	C24H28N2O3
CAS#	1204313-51-8
Inchi	InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)
Inchi Key	PURKAOJPTOLRMP-UHFFFAOYSA-N
SMILES	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C
Size	5mg
Supplier Page	http://www.selleckchem.com/products/icotinib-hydrochloride.html
Additional Information	https://file.selleck.cn/downloads/struct/E4884-Icotinib-Hydrochloride-chemical-structure.png